OVARIAN CANCER RESEARCH FUND INC: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization
OVARIAN CANCER RESEARCH FUND INC (EIN 13-3806788)
Tax period
2024-01-01 to 2024-12-31
Filed
2025-11-05
IRS object ID
202533099349302348
Schema version
2024v5.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2025-11-05T13:35:03-06:00ReturnTs
Tax Period End2024-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN331374517PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1PKF O'CONNOR DAVIES ADVISORY LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1500 MAMARONECK AVENUE SUITE 301AddressLine1Txt
CityHARRISONCityNm
State AbbreviationNYStateAbbreviationCd
ZIP105281633ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2024-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133806788EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE OVARIAN CANCER RESEARCH FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlOVARBusinessNameControlTxt
Phone2122681002PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line145 ROCKEFELLER PLAZA 20TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101113193ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonAUDRA L MORANPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone2122681002PhoneNum
Signature2025-11-05SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonMELISSA MODELSONPreparerPersonNm
PTINP01603524PTIN
Phone9143818900PhoneNum
Preparation2025-11-05PreparationDt
FieldValueIRS element (for citing)
Tax2024TaxYr
Build TS2025-03-06 01:10:19ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1OVARIAN CANCER RESEARCH ALLIANCEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerAUDRA L MORANPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line145 ROCKEFELLER PLAZA 20TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101113193ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$21,854,917GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.OCRAHOPE.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1994FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionOVARIAN CANCER RESEARCH ALLIANCE IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.ActivityOrMissionDesc
Voting Members Governing Body19VotingMembersGoverningBodyCnt
Voting Members Independent19VotingMembersIndependentCnt
Total Employee21TotalEmployeeCnt
Total Volunteers1869TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$11,556,311PYContributionsGrantsAmt
CY Contributions Grants$8,538,194CYContributionsGrantsAmt
PY Program Service Revenue$438,937PYProgramServiceRevenueAmt
CY Program Service Revenue$301,023CYProgramServiceRevenueAmt
PY Investment Income$1,447,267PYInvestmentIncomeAmt
CY Investment Income$1,219,860CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue-$11,079CYOtherRevenueAmt
PY Total Revenue$13,442,515PYTotalRevenueAmt
CY Total Revenue$10,047,998CYTotalRevenueAmt
PY Grants And Similar Paid$8,117,910PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$6,428,064CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$3,064,716PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$2,887,953CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,425,591CYTotalFundraisingExpenseAmt
PY Other Expenses$2,570,134PYOtherExpensesAmt
CY Other Expenses$4,240,499CYOtherExpensesAmt
PY Total Expenses$13,752,760PYTotalExpensesAmt
CY Total Expenses$13,556,516CYTotalExpensesAmt
PY Revenues Less Expenses-$310,245PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$3,508,518CYRevenuesLessExpensesAmt
Total Assets BOY$39,203,357TotalAssetsBOYAmt
Total Assets EOY$38,070,603TotalAssetsEOYAmt
Total Liabilities BOY$14,720,293TotalLiabilitiesBOYAmt
Total Liabilities EOY$14,914,782TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$24,483,064NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$23,155,821NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOVARIAN CANCER RESEARCH ALLIANCE (OCRA) IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$7,227,647ExpenseAmt
Grant$6,318,064GrantAmt
Revenue$0RevenueAmt
DescOVARIAN CANCER RESEARCH ALLIANCE WAS FOUNDED IN 1994 (AS THE OVARIAN CANCER RESEARCH FUND, INC.) AND IS A FULL-SPECTRUM ORGANIZATION FUNDING MEDICAL RESEARCH, ADVOCATING ON BEHALF OF PATIENTS AND PROVIDING SUPPORT AND RESOURCES TO PATIENTS AND THEIR FAMILIES.OVARIAN CANCER IS THE DEADLIEST OF ALL GYNECOLOGIC CANCERS AND RANKS FIFTH AS THE CAUSE OF CANCER DEATH IN WOMEN. IN 2024, THERE WERE 19,680 NEW CASES OF OVARIAN CANCER AND 12,740 DEATHS FROM THE DISEASE IN THE UNITED STATES. THE ACCOMPLISHMENTS OF OCRA'S PROGRAMS REFLECT OUR COMMITMENT TO THE OVARIAN AND GYNECOLOGIC CANCER COMMUNITIES. SINCE 1998, OCRA HAS AWARDED 435 GRANTS FOR OVARIAN AND RELATED CANCER RESEARCH TO PHYSICIANS AND SCIENTISTS AT 99 LEADING MEDICAL CENTERS, WHICH IS AN INVESTMENT TOTALING OVER $129 MILLION. THANKS TO THE GENEROSITY OF OUR DONORS, OUR INVESTIGATORS ARE WORKING ON MANY FRONTS TO DEFEAT OVARIAN CANCER. BY DEVELOPING INNOVATIVE STRATEGIES FOR EARLY DETECTION AND EXPLORING THE GENETICS THAT INCREASE RISK FOR OVARIAN CANCER, WE HOPE TO SAVE WOMEN'S LIVES BY FINDING THE CANCER EARLY OR STOPPING IT BEFORE IT EVEN STARTS. RESEARCHERS ARE GAINING INSIGHTS INTO THE MANY TYPES OF OVARIAN AND RELATED CANCERS TO DETERMINE THE ORIGINS, WHICH MAY LEAD TO MORE EFFECTIVE TESTING AND EFFECTIVE IMMUNOTHERAPY TREATMENT OPTIONS. FURTHERMORE, THEY ARE IDENTIFYING NEW AND BETTER TREATMENTS TO IMPROVE OVERALL SURVIVAL, PREVENT DRUG RESISTANCE, MINIMIZE SIDE EFFECTS, PREVENTING RECURRENCE AND METASTASIS, AND ENHANCE PATIENTS' QUALITY OF LIFE. OCRA CONTINUED THE HEALTH EQUITY RESEARCH GRANTS BEGUN IN 2023. THESE GRANTS FOCUS ON IMPROVING HEALTH EQUITY IN THE GYNECOLOGIC CANCER SPACE.ACCOMPLISHMENTS ACHIEVED AS A RESULT OF OCRA GRANTS INCLUDE:IDENTIFIED A MOLECULE THAT COULD BE KEY TO IMPROVING IMMUNE RESPONSE AGAINST OVARIAN CANCER; HIGHLIGHTED THE NEED FOR INDIVIDUAL ASSESSMENT OF COMPLEX VARIANTS TO CORRECTLY IDENTIFY INDIVIDUALS AT RISK; SOUGHT TO UNDERSTAND WHY CERTAIN OVARIAN CANCER CELLS RESIST OLAPARIB TREATMENT, AND DISCOVERED THAT INTRODUCING A SECOND DRUG (MIFEPRISTONE) WHILE TARGETING CERTAIN CELLS (POLYPLOID GIANT CANCER CELLS) MAY OFFER A SOLUTION; IDENTIFIED A PREVIOUSLY UNKNOWN CHEMORESISTANT PATHWAY IN HGSC WHICH LED TO WORKING ON A NEW THERAPY TO OVERCOME THIS; FOUND THAT MESOTHELIAL CELLS ARE IMPORTANT TO THE INITIAL STAGES OF OVARIAN CANCER GROWTH IN THE ABDOMINAL CAVITY; SHED NEW LIGHT ON HOW THE MOST COMMON SUBTYPE OF OVARIAN CANCER DEVELOPS AND METASTASIZES, BY IDENTIFYING A KEY MOLECULE THAT ALLOWS MALIGNANCIES IN THE FALLOPIAN TUBE TO MIGRATE TO THE OVARIES AND CONTINUE TO GROW; UNCOVERED SEVERAL MECHANISMS OF IMMUNE ESCAPE TO HELP EXPLAIN SOME OVARIAN CANCERS' RESISTANCE TO IMMUNOTHERAPY; SHOWN THAT RUCAPARIB EXTENDS PROGRESSION FREE SURVIVAL IN OVARIAN CANCER; DISCOVERED THAT 18% OF OVARIAN CANCER CASES INVOLVE INHERITED MUTATIONS; PINPOINTED TWO GENES THAT TRIGGER OVARIAN CANCER; IDENTIFIED A NEW THERAPEUTIC STRATEGY FOR CLEAR CELL OVARIAN CANCER; SHOWN HOW A PARP/IMMUNE THERAPY COMBO SHOWS PROMISE; DEMONSTRATED HOW GENE THERAPY MAY HELP PATIENTS WITH RECURRENT DISEASE; SHED LIGHT ON HOW OVARIAN CANCER GROWS; DISCOVERED THAT ANALYZING DATA FROM PAP SMEARS COULD HELP DETECT ENDOMETRIAL AND OVARIAN CANCER; ESTABLISHED THERE IS NO LINK BETWEEN OBESITY AND RISK FOR THE MOST COMMON TYPE OF OVARIAN CANCER; SHOWN THAT FGFR4 IS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET FOR OVARIAN CANCER; DEFINED SIMILARITIES BETWEEN SOME ENDOMETRIAL, BREAST AND OVARIAN CANCERS; EXPLAINED HOW AN EXPERIMENTAL DRUG MAY BE HELPFUL IN FIGHTING PLATINUM-RESISTANT OVARIAN CANCER; IDENTIFIED AREAS OF THE HUMAN GENOME THAT ARE LINKED TO INCREASED RISK FOR OVARIAN CANCER; IDENTIFIED BIOMARKERS THAT CAN BE USED TO MONITOR THE DEVELOPMENT OF PLATINUM RESISTANCE THERAPIES; STUDIED MACROPHAGES TO IMPROVE TREATMENT; IDENTIFIED NOVEL BIOMARKERS OF HGSOC AND SPECIFIC DRUG TARGETS; TARGETED MDM2 DEGRADATION AS A NOVEL TREATMENT FOR OVARIAN CANCER; USED MACHINE LEARNING TO BRIDGE THE GAP BETWEEN DISPARATE DATA SETS SPECIFICALLY IN PATIENTS WITH HGSOC; DOSED THE FIRST PATIENTS IN THE CLINICAL TRIAL "IMMUNOTHERAPY PLATFORM STUDY IN PLATINUM RESISTANT HIGH GRADE SEROUS OVARIAN CANCER (IPROC)" (NCT04918186); FOUND KEY PROTEINS IN HGSOC CANCER CELLS WHICH RESULTED IN COMBINED TREATMENT OPTIONS WHICH RESULTED IN SMALLER TUMORS AND LONGER SURVIVAL; AND SHOWED HOW SURGICAL REMOVAL OF FALLOPIAN TUBES MAY REDUCE OVARIAN CANCER RISK.IN 2024 ALONE, OCRA RESEARCHERS: DEVELOPED A POSSIBLE FRAMEWORK FOR THE DEVELOPMENT OF NOVEL STRATEGIES TO IMPROVE TREATMENT OUTCOMES; SHOWED HOW RNF168 PRODUCES AND READS CHROMATIN UBIQUITYLATION; UNCOVERED SEVERAL MECHANISMS OF IMMUNE ESCAPE TO HELP EXPLAIN SOME OVARIAN CANCERS' RESISTANCE TO IMMUNOTHERAPY; FOUND A DECREASE IN OVARIAN CARCINOMA INCIDENCE AFTER SALPINGECTOMY FOR TREATING ECTOPIC PREGNANCY; SHOWED PARP1 IS INVOLVED IN REPAIR OF TELOMERES, AND THAT IMPAIRING THIS PROCESS CAN LEAD TO TELOMERE SHORTENING AND GENOMIC INSTABILITY THAT CAN CAUSE CANCER; DEVELOPED A PROOF OF CONCEPT STUDY TO SHOW HOW THREE DIMENSIONAL MODELING CAN SHOW HOW CANCER CELLS AND CAR-T INTERACT WHICH WILL HOPEFULLY LEAD TO BETTER TREATMENTS IN PATIENTS WITH HGSOC SOLID TUMORS; DISCOVERED THAT AGGRESSIVE OVARIAN CANCERS OFTEN SHOW SUDDEN LARGE-SCALE DNA DAMAGE, POINTING TO DISTINCT ORIGINS AND DETECTION STRATEGIES; CHARACTERIZED EXPRESSION OF NEARLY 500 PROTEINS FROM THOUSANDS OF CANCER SAMPLES, ENABLING INSIGHTS INTO TUMOR HETEROGENEITY, CANCER DEPENDENCIES, BIOMARKERS, AND THERAPEUTIC TARGETS; DISCOVERED THAT A PROTEIN CALLED EGFL6 HELPS OVARIAN TUMORS BLOCK THE IMMUNE SYSTEM'S ATTACK, BUT BLOCKING EGFL6 RESTORED THE EFFECTIVENESS OF IMMUNOTHERAPY IN MICE, SUGGESTING A PROMISING NEW TREATMENT TARGET; AND IDENTIFIED THAT LOSS OF A GENE CALLED SMARCA4 MAKES OVARIAN CANCER CELLS MORE VISIBLE TO THE IMMUNE SYSTEM, BOOSTING IMMUNE ATTACK AND SUGGESTING A NEW STRATEGY TO IMPROVE IMMUNOTHERAPY.EVERY DOLLAR DONATED BRINGS US CLOSER TO A CURE FOR THIS DEVASTATING DISEASE. FOR MORE INFORMATION OR TO JOIN US IN OUR FIGHT, PLEASE VISIT OCRA'S WEBSITE AT WWW.OCRAHOPE.ORG.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,708,288ExpenseAmt
Grant$35,000GrantAmt
Revenue$0RevenueAmt
DescBEYOND OUR CONFERENCE, OCRA HAS ADDITIONAL PATIENT EDUCATION AND SUPPORT PROGRAMS AND ENGAGES IN ADVOCACY ON BEHALF OF WOMEN WITH GYNECOLOGIC CANCERS. OUR WEBSITE IS A COMPREHENSIVE SOURCE OF EDUCATIONAL INFORMATION, AND THROUGHOUT THE COURSE OF THE YEAR WE HOLD A SERIES OF FREE, EDUCATIONAL WEBINARS ON A RANGE OF TOPICS RELATED TO THE LATEST RESEARCH, TREATMENT, AND SURVIVORSHIP.OCRA OFFERS FREE GENETIC TESTING TO QUALIFIED HIGH RISK INDIVIDUALS AND FACILITATES ACCESS TO CERTIFIED GENETIC COUNSELORS. SINCE THE LAUNCH OF THE PROGRAM, OCRA HAS HELPED OVER 3,000 PEOPLE LEARN ABOUT THEIR GENETIC RISK FOR GYNECOLOGIC CANCER. OCRA'S PATIENT-SUPPORT LINE IS STAFFED BY OUR SOCIAL WORK TEAM DURING BUSINESS HOURS MONDAY THROUGH FRIDAY AND IS AVAILABLE TO ANYONE SEEKING INFORMATION, SUPPORT, PATIENT NAVIGATION, OR RESOURCE REFERRALS (MEDICAL ADVICE IS NOT PROVIDED). OUR WOMAN TO WOMAN PROGRAM IS A PEER-TO-PEER SUPPORT PROGRAM FOR WOMEN WITH GYNECOLOGIC CANCER. OCRA OFFERS BOTH A NATIONAL WOMAN TO WOMAN PROGRAM AND PROVIDES FINANCIAL SUPPORT TO HELP HOSPITALS AND OTHER ORGANIZATIONS START LOCAL WOMAN TO WOMAN PROGRAMS, WHICH ARE NOW AT MORE THAN 19 SITES ACROSS THE COUNTRY. OUR STAYING CONNECTED SUPPORT SERIES, WHICH LAUNCHED IN 2020, NOW OFFERS FOUR WEEKLY WORKSHOPS AND THREE MONTHLY WORKSHOPS WHICH PROVIDE ALL IMPACTED BY OVARIAN OR RELATED GYNECOLOGIC CANCERS A WAY TO LEARN, SHARE, AND CONNECT. OUR ARTS PROGRAM-EXPRESS YOURSELF AND BOOK CLUB- OFFERS A COMBINATION OF THERAPEUTIC ARTS, POETRY, READING AND CREATIVE EXPRESSION, AND COMMUNITY BUILDING ACTIVITIES WITH 1865 REGISTERED IN 2024. OCRA PARTNERS WITH INSPIRE.COM TO OFFER AN ONLINE SUPPORT COMMUNITY THAT HAS OVER 85,000 MEMBERS WORLD-WIDE.OCRA IS COMMITTED TO ENCOURAGING THE NEXT GENERATION OF HEALTHCARE PROFESSIONALS TO FOCUS ON THE CRITICAL NEEDS OF THOSE DIAGNOSED WITH GYNECOLOGIC CANCER, WHETHER AT BENCH OR BEDSIDE.THROUGH OCRA'S ONCOLOGY SOCIAL WORK FIELD PLACEMENT, WE ACCEPT TOP MASTER OF SOCIAL WORK CANDIDATES TO TRAIN WITH OUR LICENSED CLINICAL SOCIAL WORKERS TO ADDRESS THE SPECIFIC NEEDS OF OUR COMMUNITY.OCRA'S SURVIVORS TEACHING STUDENTS (STS) PROGRAM TRAINS OVARIAN CANCER SURVIVORS AND CAREGIVERS TO CONDUCT PRESENTATIONS IN MEDICAL EDUCATION PROGRAMS TO EDUCATE FUTURE HEALTHCARE PROVIDERS ABOUT OVARIAN CANCER. SURVIVORS SHARE THEIR STORIES OF DIAGNOSIS, TREATMENT AND BEYOND, ALONG WITH FACTS ABOUT THE DISEASE. IN 2024, MORE THAN 980 SURVIVOR VOLUNTEERS DELIVERED 439 PRESENTATIONS IN THE US, UK, AND AUSTRALIA REACHING OVER 10,000 MEDICAL, NURSING, AND PHYSICIAN'S ASSISTANT STUDENTS. THESE PRESENTATIONS ENSURE THE NEXT GENERATION OF HEALTH CARE PROVIDERS UNDERSTAND BASIC FACTS ABOUT THE DISEASE, ARE AWARE OF RISK FACTORS, AND CAN IDENTIFY THE SIGNS AND SYMPTOMS OF OVARIAN CANCER, HELPING ENSURE A TIMELY DIAGNOSIS.OVARIAN CANCER RESEARCH ALLIANCE IS A POWERFUL VOICE ON CAPITOL HILL, IN STATEHOUSES AROUND THE COUNTRY AND WITH FEDERAL AGENCIES FOR EVERYONE TOUCHED BY GYNECOLOGIC CANCER. EACH YEAR OCRA PLAYS A CRITICAL ROLE IN HELPING TO SECURE MORE THAN $200 MILLION IN FEDERAL FUNDING FOR OVARIAN CANCER RESEARCH AND EDUCATION. IN ADDITION, OUR GROWING ADVOCATE LEADER PROGRAM TRAINS MEMBERS OF THE GYNECOLOGIC CANCER COMMUNITY TO RAISE AWARENESS THROUGH NEWS ARTICLES AND OUTREACH, DEVELOP RELATIONSHIPS WITH THEIR ELECTED OFFICIALS, AND FIGHT FOR INCREASED FUNDING FOR GYNECOLOGIC CANCER RESEARCH THROUGHOUT THE COUNTRY.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$982,758ExpenseAmt
Grant$75,000GrantAmt
Revenue$301,023RevenueAmt
DescEACH YEAR, OCRA BRINGS TOGETHER OVARIAN CANCER PATIENTS, SURVIVORS AND CAREGIVERS AT THE INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE, A THREE DAY-LONG EVENT FILLED WITH INFORMATIONAL SESSIONS FEATURING EXPERT SPEAKERS, FUN AND COMMUNITY. IN 2024, MORE THAN 600 PEOPLE FROM ALL 50 STATES AND 14 COUNTRIES CAME TOGETHER VIRTUALLY FOR THIS EVENT. THE SPIRIT OF UNITY AND HOPE IS ALWAYS STRONG AND ATTENDEES CAN LEARN MORE ABOUT THEIR DIAGNOSIS, TREATMENT, AND SURVIVORSHIP. SESSIONS FEATURE TOP OVARIAN AND GYNECOLOGIC CANCER EXPERTS WHO GENEROUSLY GIVE OF THEIR TIME, PRESENTING THE LATEST IN TREATMENTS, RESEARCH, MANAGING RECURRENCE, GENETICS, NUTRITION, CARETAKER AND SUPPORTER CARE, SUPPORT FOR YOUNG WOMEN, ADVOCACY, AND SO MUCH MORE.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$9,918,693TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control Ent0TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document61IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee21EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members19GoverningBodyVotingMembersCnt
Independent Voting Member19IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1AUDRA L MORANBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2122681002PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line145 ROCKEFELLER PLAZA 20TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP101113193ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
JOHN ORRICO
CHAIR3.000.00Yes (X)Yes (X)$0$0$0
MATTHEW NEAL MILLER
VICE PRESIDENT2.000.00Yes (X)Yes (X)$0$0$0
MARK TESSAR
TREASURER2.000.00Yes (X)Yes (X)$0$0$0
ROBIN S COHEN
SECRETARY2.000.10Yes (X)Yes (X)$0$0$0
DEBRA BIRNBAUM
DIRECTOR1.000.00Yes (X)$0$0$0
THOMAS C LIEBMAN
DIRECTOR1.000.00Yes (X)$0$0$0
JEANNETTE CHANG
DIRECTOR1.000.00Yes (X)$0$0$0
DR CARMEL J COHEN
DIRECTOR1.000.00Yes (X)$0$0$0
MEI-LI DA SILVA VINT ESQ
DIRECTOR1.000.00Yes (X)$0$0$0
ANDREW FEUERSTEIN ESQ
DIRECTOR1.000.00Yes (X)$0$0$0
CAROL J HAMILTON
DIRECTOR1.000.00Yes (X)$0$0$0
JOHN W HANSBURY ESQ
DIRECTOR1.000.10Yes (X)$0$0$0
CAROLINE HIRSCH
DIRECTOR1.000.00Yes (X)$0$0$0
VERONICA JORDAN
DIRECTOR1.000.00Yes (X)$0$0$0
DANA L MARK ESQ
DIRECTOR1.000.00Yes (X)$0$0$0
CHRIS NEWCOMB
DIRECTOR1.000.00Yes (X)$0$0$0
LISA SCHREIBER
DIRECTOR1.000.00Yes (X)$0$0$0
ELLE SIMONE SCOTT
DIRECTOR1.000.00Yes (X)$0$0$0
CHRISTOPHER TILBERIS
DIRECTOR1.000.00Yes (X)$0$0$0
AUDRA L MORAN
PRESIDENT & CEO40.000.10Yes (X)$324,287$0$33,952
JONATHAN ZEIDMAN
CHIEF DEVELOPMENT OFFICER40.000.00$189,019$0$53,359Yes (X)
SARAH C DEFEO
CHIEF PROGRAM OFFICER40.000.00$166,391$0$67,294Yes (X)
TRACY MOORE
VICE PRESIDENT, SUPPORT & EDUCATION40.000.00$157,837$0$27,142Yes (X)
CHAD RAMSEY
VICE PRESIDENT, POLICY40.000.00$123,276$0$25,678Yes (X)
NICOLE WARGO
VP - PHILANTHROPIC PARTNER40.000.00$126,274$0$36,184Yes (X)
JESSICA HUGHSON ANDRADE
SENIOR DIRECTOR, STRATEGIC ALLIANCE40.000.00$108,675$0$23,247Yes (X)
BRIAN PHAIR
DIRECTOR, DONOR RELATIONS40.000.00$102,012$0$5,214Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,297,771TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$272,070TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K8IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
ADC STRATEGIC COMMUNICATIONS
14 KNOB HLPUTNAM VALLEYNY105793314COMMUNICATION SERVICES$213,604
BENJAMIN AUSTIN
32 MAGNOLIA DRIVEDOBBS FERRYNY10522MARKETING CONSULTING SERVICES$190,589
AMPLIFI
600 RYERSON ROAD SUITE GLINCOLN PARKNJ07035MAILING SERVICES$170,647
COSGROVE ACCOUNTING
11161 E STATE RD 70 STE 110-693LAKEWOOD RANCHFL34202ACCOUNTING SERVICES$160,524
COLOR HEALTH
831 MITTEN ROAD STE 100BURLINGAMECA94010HEREDITARY TESTING KITS$110,464
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K5CntrctRcvdGreaterThan100KCnt
Fundraising$195,891FundraisingAmt
All Other Contributions$8,342,303AllOtherContributionsAmt
Noncash Contributions$684,681NoncashContributionsAmt
Total Contributions$8,538,194TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescCONFERENCESDesc
Business900099BusinessCd
Total Revenue Column$301,023TotalRevenueColumnAmt
Related Or Exempt Func Income$301,023RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$301,023TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$992,906TotalRevenueColumnAmt
Exclusion$992,906ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$12,022,794SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$11,795,840SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$226,954SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$226,954TotalRevenueColumnAmt
Exclusion$226,954ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$195,891ContriRptFundraisingEventAmt
Fundraising Direct Expenses$11,079FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$11,079TotalRevenueColumnAmt
Exclusion-$11,079ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,047,998TotalRevenueColumnAmt
Related Or Exempt Func Income$301,023RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,208,781ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$5,673,064TotalAmt
Program Services$5,673,064ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$755,000TotalAmt
Program Services$755,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$834,302TotalAmt
Program Services$648,759ProgramServicesAmt
Management And General$137,600ManagementAndGeneralAmt
Fundraising$47,943FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,474,990TotalAmt
Program Services$689,723ProgramServicesAmt
Management And General$165,529ManagementAndGeneralAmt
Fundraising$619,738FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$52,576TotalAmt
Program Services$25,891ProgramServicesAmt
Management And General$5,947ManagementAndGeneralAmt
Fundraising$20,738FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$351,887TotalAmt
Program Services$179,809ProgramServicesAmt
Management And General$45,332ManagementAndGeneralAmt
Fundraising$126,746FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$174,198TotalAmt
Program Services$99,122ProgramServicesAmt
Management And General$22,750ManagementAndGeneralAmt
Fundraising$52,326FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$169,371TotalAmt
Program Services$8,938ProgramServicesAmt
Management And General$160,433ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$215,632TotalAmt
Management And General$215,632ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$94,165TotalAmt
Management And General$94,165ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,070,763TotalAmt
Program Services$802,454ProgramServicesAmt
Management And General$257,486ManagementAndGeneralAmt
Fundraising$10,823FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$251,942TotalAmt
Program Services$150,547ProgramServicesAmt
Management And General$30,725ManagementAndGeneralAmt
Fundraising$70,670FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$727,841TotalAmt
Program Services$306,672ProgramServicesAmt
Management And General$61,593ManagementAndGeneralAmt
Fundraising$359,576FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$201,486TotalAmt
Program Services$99,368ProgramServicesAmt
Management And General$49,662ManagementAndGeneralAmt
Fundraising$52,456FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$174,859TotalAmt
Program Services$99,489ProgramServicesAmt
Management And General$22,851ManagementAndGeneralAmt
Fundraising$52,519FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$53,905TotalAmt
Program Services$43,613ProgramServicesAmt
Management And General$10,292ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$129,842TotalAmt
Program Services$129,842ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$12,375TotalAmt
Program Services$7,042ProgramServicesAmt
Management And General$1,616ManagementAndGeneralAmt
Fundraising$3,717FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$18,852TotalAmt
Program Services$10,727ProgramServicesAmt
Management And General$2,462ManagementAndGeneralAmt
Fundraising$5,663FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtManagement And GeneralManagementAndGeneralAmtProgram ServicesProgramServicesAmtFundraisingFundraisingAmt
LEASE TERMINATION$925,000$925,000
GENETIC TESTING$183,556$183,556
OTHER OPERATING EXPENSE$5,465$2,449$1,973$1,043
MOVING EXPENSES$2,770$360$1,579$831

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$2,675TotalAmt
Program Services$1,525ProgramServicesAmt
Management And General$348ManagementAndGeneralAmt
Fundraising$802FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$13,556,516TotalAmt
Program Services$9,918,693ProgramServicesAmt
Management And General$2,212,232ManagementAndGeneralAmt
Fundraising$1,425,591FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,908,312BOYAmt
EOY$2,107,359EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,873,971BOYAmt
EOY$1,049,345EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$669,631BOYAmt
EOY$1,212,071EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$112,347BOYAmt
EOY$69,269EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$313,290LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$233,290LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$2,375BOYAmt
EOY$80,000EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$34,459,485BOYAmt
EOY$33,033,627EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$177,236BOYAmt
EOY$518,932EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$39,203,357BOYAmt
EOY$38,070,603EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$247,245BOYAmt
EOY$361,274EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$14,388,180BOYAmt
EOY$14,132,020EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$84,868BOYAmt
EOY$421,488EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$14,720,293BOYAmt
EOY$14,914,782EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$12,729,445BOYAmt
EOY$10,207,440EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$11,753,619BOYAmt
EOY$12,948,381EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$24,483,064BOYAmt
EOY$23,155,821EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$39,203,357BOYAmt
EOY$38,070,603EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$3,508,518ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$2,002,259NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$179,016OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,224,819CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$11,263,534CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$15,386,443CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$11,556,311CurrentTaxYearMinus1YearAmt
Current Tax Year$8,538,194CurrentTaxYearAmt
Total$52,969,301TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,224,819CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$11,263,534CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$15,386,443CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$11,556,311CurrentTaxYearMinus1YearAmt
Current Tax Year$8,538,194CurrentTaxYearAmt
Total$52,969,301TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$9,979,276SubstantialContributorsTotAmt
Public Support Total170$42,990,025PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$611,749CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$542,131CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$710,226CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,095,100CurrentTaxYearMinus1YearAmt
Current Tax Year$992,906CurrentTaxYearAmt
Total$3,952,112TotalAmt
FieldValueIRS element (for citing)
Total Support$56,921,413TotalSupportAmt
Gross Receipts Rltd Activities$1,777,671GrossReceiptsRltdActivitiesAmt
Public Support CY1700.75530PublicSupportCY170Pct
Public Support PY1700.71710PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind
Public Support PY5090.60030PublicSupportPY509Pct
Investment Income PY0.06190InvestmentIncomePYPct

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$7,500FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$14,895FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$22,395FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$12,014,365FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$12,036,760FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$751,838FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$187,960FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$704,647CurrentYearMinus3Amt
Current Year Minus2$723,133CurrentYearMinus2Amt
Current Year Minus1$837,638CurrentYearMinus1Amt
Current Year$751,838CurrentYearAmt
Total$3,017,256TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$4,525,884LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year$22,395CurrentYearAmt
Total$22,395TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$176,162CurrentYearMinus3Amt
Current Year Minus2$180,783CurrentYearMinus2Amt
Current Year Minus1$209,410CurrentYearMinus1Amt
Current Year$187,960CurrentYearAmt
Total$754,315TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,131,473GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year$7,500CurrentYearAmt
Total$7,500TotalAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$115,471OtherCostOrOtherBasisAmt
Depreciation$115,471DepreciationAmt
Book Value$0BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$197,819OtherCostOrOtherBasisAmt
Depreciation$117,819DepreciationAmt
Book Value$80,000BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$80,000TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescLEASE LIABILITYDesc
Amt$421,488Amt
FieldValueIRS element (for citing)
Total Liability$421,488TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$12,468,752TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$2,002,259NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$512,660DonatedServicesAndUseFcltsAmt
Revenue Not Reported$2,514,919RevenueNotReportedAmt
Revenue Subtotal$9,953,833RevenueSubtotalAmt
Investment Expenses Not Incld$94,165InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$94,165RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$10,047,998TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$13,795,995TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$512,660DonatedServicesUseFcltsAmt
Expenses Not Reported$512,660ExpensesNotReportedAmt
Expenses Subtotal$13,283,335ExpensesSubtotalAmt
Investment Expenses Not Incld2$94,165InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$179,016OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$273,181ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$13,556,516TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART X, LINE 2:OCRA RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT OCRA HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. OCRA IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2021.
PART XII, LINE 4B - OTHER ADJUSTMENTS:GRANT REFUNDS 179,016.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND & GREENLAND)00GRANTMAKING$720,000
NORTH AMERICA00GRANTMAKING$35,000
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$755,000SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$755,000TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
EUROPE (INCLUDING ICELAND & GREENLAND)RESEARCH$720,000WIRE$0
NORTH AMERICARESEARCH$35,000WIRE$0
FieldValueIRS element (for citing)
Total501c3 Org2Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:OCRA MONITORS THE USE OF GRANT FUNDS BY REQUIRING ALL GRANTEES TO SUBMIT YEARLY FINANCIAL AND NARRATIVE PROGRESS REPORTS DETAILING THE USE OF FUNDS AND PROGRAM OUTCOMES. THESE REPORTS ARE REVIEWED BY OCRA TO CONFIRM COMPLIANCE WITH THE STATED CHARITABLE OBJECTIVES.
PART I, LINE 3:THE ORGANIZATION USED THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR EXPENDITURES.

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1OVARIAN CYCLE & FITNESSEvent1Nm
Gross Receipts Event1$195,891GrossReceiptsEvent1Amt
Charitable Contri Event1$195,891CharitableContriEvent1Amt
Other Direct Expenses Event1$11,079OtherDirectExpensesEvent1Amt
Gross Receipts Total$195,891GrossReceiptsTotalAmt
Charitable Contributions Tot$195,891CharitableContributionsTotAmt
Oth Direct Expnss Total Events$11,079OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$11,079DirectExpenseSummaryEventsAmt
Net Income Summary-$11,079NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (14 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxt
THE GEORGE WASHINGTON UNIVERSITY
CO/ TAX DEPARTMENT 44983 KNOLLSQUARE 2023ASHBURNVA201474198530196584501(C)(3)$900,000$0RESEARCH
UNIVERSITY OF MINNESOTA
COURTHOUSE DEPT 106 213 MAIN AVE NBAGLEYMN56621416007513STATE OF MN$900,000$0RESEARCH
CHILDREN'S HOSPITAL CORPORATION (DBA BOSTON CHILDREN'S HOSPITAL)
300 LONGWOOD AVEBOSTONMA02115042774441501(C)(3)$899,439$0RESEARCH
NORTHWESTERN UNIVERSITY
2145 SHERIDAN ROAD ROOM L291EVANSTONIL602083102362167817501(C)(3)$550,000$0RESEARCH
WASHINGTON UNIVERSITY IN ST LOUIS
WU-ACCT SVCS 7425 FORSYTH BLVDSAINT LOUISMO631052151430653611501(C)(3)$549,837$0RESEARCH
JOHNS HOPKINS UNIVERSITY
SOM 733 NORTH BROADWAY SUITE 117BALTIMOREMD21205520595110501(C)(3)$450,000$0RESEARCH
H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC
12902 MAGNOLIA DRIVETAMPAFL33612592451713501(C)(3)$449,803$0RESEARCH
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE CB1270CHAPEL HILLNC275991270566001393STATE OF NC$200,000$0RESEARCH
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
7000 FANNIN ST STE 1006HOUSTONTX770305400741761309STATE OF TX$199,999$0RESEARCH
THE UNIVERSITY OF NEW MEXICO
1700 LOMAS BLVD NEALBUQUERQUENM871063807856000642STATE OF NM$199,987$0RESEARCH
STANFORD UNIVERSITY
485 BROADWAY MAIL CODE 8838REDWOOD CITYCA94063941156365501(C)(3)$100,000$0RESEARCH
UNIVERSITY OF ILLINOIS AT CHICAGO
506 S WRIGHT ST 209 HAB NO MC339URBANAIL61801376000511STATE OF IL$99,999$0RESEARCH
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 301429HOUSTONTX77230746001118STATE OF TX$99,000$0RESEARCH
SOCIETY OF GYNECOLOGIC ONCOLOGY
230 W MONROE STREET SUITE 710CHICAGOIL606064703611657046501(C)(6)$75,000$0RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org13Total501c3OrgCnt
Total Other Org1TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationOCRA MONITORS THE USE OF GRANT FUNDS BY REQUIRING ALL GRANTEES TO SUBMIT YEARLY FINANCIAL AND NARRATIVE PROGRESS REPORTS DETAILING THE USE OF FUNDS AND PROGRAM OUTCOMES. THESE REPORTS ARE REVIEWED BY OCRA TO CONFIRM COMPLIANCE WITH THE STATED CHARITABLE OBJECTIVES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (5 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
AUDRA L MORAN
PRESIDENT & CEO$324,287$0$0$0$0$0$12,971$0$20,981$0$358,239$0$0$0
JONATHAN ZEIDMAN
CHIEF DEVELOPMENT OFFICER$189,019$0$0$0$0$0$0$0$53,359$0$242,378$0$0$0
SARAH C DEFEO
CHIEF PROGRAM OFFICER$166,391$0$0$0$0$0$7,808$0$59,486$0$233,685$0$0$0
TRACY MOORE
VICE PRESIDENT, SUPPORT & EDUCATION$157,837$0$0$0$0$0$6,314$0$20,828$0$184,979$0$0$0
NICOLE WARGO
VP - PHILANTHROPIC PARTNER$126,274$0$0$0$0$0$5,360$0$30,824$0$162,458$0$0$0

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution16ContributionCnt
Noncash Contributions Rpt F990$684,681NoncashContributionsRptF990Amt
Method Of Determining RevenuesSALES PRICEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (B):FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTORS IN PART I, COLUMN (B) OF SCHEDULE M.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, ITEM CDBA: OVARIAN CANCER RESEARCH ALLIANCE DBA: THE EDMEE FIRTH FUND FOR RESEARCH ON OVARIAN CANCER DBA: THE EDMEE FIRTH FUND FOR RESEARCH IN OVARIAN CANCER
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS, AUDIT COMMITTEE, TREASURER, AND THE CEO, AND IS REVIEWED WITH THE EXTERNAL CPA PRIOR TO ITS FILING WITH THE IRS.
FORM 990, PART VI, SECTION B, LINE 12COCRA'S CONFLICT OF INTEREST POLICY (THE "POLICY") APPLIES TO DIRECTORS, OFFICERS AND OTHER EMPLOYEES OR OTHER PERSONS IN A POSITION TO INFLUENCE POLICY OR EXPENDITURES ("KEY PERSONS") WHO ARE ANNUALLY PROVIDED A COPY OF THE POLICY. THE POLICY INCLUDES A REPORTING FORM FOR EXISTING OR POTENTIAL CONFLICTS, AND EACH KEY PERSON IS REQUIRED TO COMPLETE ANNUALLY THE REPORTING FORM. IN CONNECTION WITH ANY PROPOSED TRANSACTION OR ARRANGEMENT BETWEEN OCRA AND ANY SUCH KEY PERSON OR RELATED PERSONS OR ENTITIES THAT RAISES AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST, THE KEY PERSON MUST DISCLOSE THE EXISTENCE AND NATURE OF HIS OR HER RELATIONSHIP AND FINANCIAL INTEREST TO THE PRESIDENT OR THE CHAIR OR CO-CHAIR OF THE BOARD OF DIRECTORS OR THE CHAIR OF ANY AUTHORIZED COMMITTEE. THE POLICY PROVIDES FOR CONSIDERATION OF ANY SUCH TRANSACTION OR ARRANGEMENT BY BOARD OR COMMITTEE MEMBERS BY FOLLOWING CERTAIN MEETING, DISCUSSION, VOTING AND DOCUMENTATION PROCEDURES. OTHER THAN TO PROVIDE INFORMATION OR RESPOND TO QUESTIONS, THE KEY PERSON IS EXCLUDED FROM THE DISCUSSION AND THE DECISION OF WHETHER A CONFLICT OF INTEREST EXISTS.
FORM 990, PART VI, SECTION B, LINE 15OCRA HAS A COMPENSATION COMMITTEE WHICH MEETS ANNUALLY TO REVIEW THE COMPENSATION OF THE CEO. THE COMPENSATION COMMITTEE DETERMINES THE CEO'S COMPENSATION BY UTILIZING DATA FROM COMPARABLY-SIZED ORGANIZATIONS (OBTAINED FORM 990 FILINGS). THE COMPENSATION DECISION IS DOCUMENTED IN THE RECORDS OF THE ORGANIZATION. SALARY INCREASES FOR KEY EMPLOYEES ARE RECOMMENDED BY THE CEO TO THE COMPENSATION COMMITTEE AFTER AN ANNUAL EVALUATION IS COMPLETED. THE COMPENSATION DECISION IS DOCUMENTED IN THE RECORDS OF THE ORGANIZATION.
FORM 990, PART VI, SECTION C, LINE 19FINANCIAL STATEMENTS ARE AVAILABLE ON OCRA'S WEBSITE. ALL OTHER DOCUMENTS ARE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 9:GRANT REFUNDS 179,016.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1OVARIAN CANCER NATIONAL ALLIANCEBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11101 14TH STREET NW SUITE 850AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd
FieldValueIRS element (for citing)
EIN311581756EIN
Primary ActivitiesEDUCATION AND ADVOCACYPrimaryActivitiesTxt
Legal Domicile StateDCLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity StatusLINE 10PublicCharityStatusTxt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1THE OVARIAN CANCER RESEARCH FUND INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Controlled OrganizationYes (1)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.